MATERIALS DRESSING WOUNDS

Brand Owner (click to sort) Address Description
QUACTIV NSC - NANO SONO COOPERATION LTD Hakidma 7 2069200 Yoqne'am Illit Israel Materials for dressing wounds; antibiotic ointments; antiseptic ointments; antibacterial ointments; disinfectants; antibacterial substances for medical purposes; antibacterial preparations for veterinary use; antibacterial sprays;Antibacterial chemical additives for paints; antibacterial chemical additives for packaging materials; antibacterial chemical additives for coating of pipes; antibacterial chemical additives for plastics, rubber or silicone; antibacterial chemical additives for surface coatings; antibacterial chemical additives for fabric and textile coatings; antibacterial chemical additives for coatings of penetrating medical devices;
QUACTIV NSC - NANO SONO COOPERATION LTD Hakidma 7 2069200 Yoqne'am Illit Israel Materials for dressing wounds; antibiotic ointments; antiseptic ointments; antibacterial ointments; disinfectants; antibacterial substances for medical purposes; antibacterial preparations for veterinary use; antibacterial sprays;Antibacterial chemical additives for paints; antibacterial chemical additives for packaging materials; antibacterial chemical additives for coating of pipes; antibacterial chemical additives for plastics, rubber or silicone; antibacterial chemical additives for surface coatings; antibacterial chemical additives for fabric and textile coatings; antibacterial chemical additives for coatings of penetrating medical devices;
TOPKIN BIOMET DEUTSCHLAND GMBH Gustav-Krone-Str. 2 Berlin 14167 Germany Materials for dressing wounds;Medical devices, namely, wound coverings in the form of degradable films;
TOPKIN Biomet Merck BioMaterials GmbH Frankfurter Strasse 250 64271 Darmstadt Germany Materials for dressing wounds;Medical devices, namely, wound coverings in the form of degradable films;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A device and method is disclosed for the treatment of early stage wounds, i.e. those wounds that have resulted in little or no breach of the skin tissue. The invention utilizes non-ablative laser or non-coherent electromagnetic radiation applied to a stage one or two wound to stimulate wound healing, destroy viral and bacterial bodies, and prevent the development of such wounds into higher stage wounds. An appropriate wavelength is chosen from the range of 193 nm to 10.6 microns, and is delivered at a power density of about at least 1 W/cm